Study of Aripiprazole (Abilify) in Children With ADHD (Attention Deficit Hyperactivity Disorder)

This study has been completed.

Sponsor:

Collaborator:

Bristol-Myers Squibb

Information provided by:

University Hospitals of Cleveland

ClinicalTrials.gov Identifier:

NCT00221962

First received: September 16, 2005

Last updated: April 27, 2007

Last verified: April 2007

History of Changes

Full Text View
Tabular View
No Study Results Posted
Disclaimer
How to Read a Study Record

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

No publications provided by University Hospitals of Cleveland

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Findling RL, Short EJ, Leskovec T, Townsend LD, Demeter CA, McNamara NK, Stansbrey RJ. Aripiprazole in children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2008 Aug;18(4):347-54.

To Top